1. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R: Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.Cancer Res 50:7057–7061, 1990.
2. Kinsel LB, Szabo E, Greene GL,Konrath aJ, Leight GS, McCarty KS, Jr.: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.Cancer Res 49:1052–1056, 1989.
3. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis.Mod Pathol 11:155–168, 1998.
4. Barnes DM, Millis RR, Beex LV, Thorpe SM, Leake RE: Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.Eur J Cancer 34:1677–1682, 1998.
5. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.J Clin Oncol 17:1474–1481, 1999.